Rosiglitazone for Patients with Diabetes: Cardiovascular Outcomes Trial Findings
Stuart Pocock
REFERENCE: ABSTRACT N Engl J Med 2007; 357: 28-381
STUART POCOCK, London School of Hygiene and Tropical Medicine
Reassuring findings about the safety of the anti-diabetic drug rosiglitazone have been published in the New England Journal of
STUART POCOCK, London School of Hygiene and Tropical Medicine
Reassuring findings about the safety of the anti-diabetic drug rosiglitazone have been published in the New England Journal of
